Ibnsina Pharma (CAI:ISPH) FCF Margin % : 5.28% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ibnsina Pharma's Free Cash Flow for the three months ended in Dec. 2023 was E£536 Mil. Ibnsina Pharma's Revenue for the three months ended in Dec. 2023 was E£10,144 Mil. Therefore, Ibnsina Pharma's FCF Margin % for the quarter that ended in Dec. 2023 was 5.28%.

As of today, Ibnsina Pharma's current FCF Yield % is 5.11%.

The historical rank and industry rank for Ibnsina Pharma's FCF Margin % or its related term are showing as below:

CAI:ISPH' s FCF Margin % Range Over the Past 10 Years
Min: -2.28 Med: -0.15 Max: 4.55
Current: 0.37

During the past 9 years, the highest FCF Margin % of Ibnsina Pharma was 4.55%. The lowest was -2.28%. And the median was -0.15%.

CAI:ISPH's FCF Margin % is ranked worse than
54.64% of 97 companies
in the Medical Distribution industry
Industry Median: 0.77 vs CAI:ISPH: 0.37

Ibnsina Pharma FCF Margin % Historical Data

The historical data trend for Ibnsina Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma FCF Margin % Chart

Ibnsina Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-0.15

1.35

-1.57

-2.08

-0.70

Ibnsina Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															9.51	-7.92	5.62	-3.40	5.28

Competitive Comparison of Ibnsina Pharma's FCF Margin %

For the Medical Distribution subindustry, Ibnsina Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ibnsina Pharma's FCF Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ibnsina Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ibnsina Pharma's FCF Margin % falls into.

Ibnsina Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ibnsina Pharma's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-236.455	/	33949.329
	=	-0.70 %

Ibnsina Pharma's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	535.857	/	10144.12
	=	5.28 %

Ibnsina Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibnsina Pharma (CAI:ISPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Industrial zone 1, PO box 91, Obour, EGY

Website

http://www.ibnsina-pharma.com

Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma (CAI:ISPH) Headlines

No Headlines